US Patent

US9630955 — Chemical compound useful as intermediate for preparing a catechol-O-methyltransferase inhibitor

Method of Use · Assigned to Bial Portela and Cia SA · Expires 2032-12-12 · 7y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent discloses a methylated intermediate that can be used to make an inhibitor of catechol-O-methyltransferase.

USPTO Abstract

There is disclosed a methylated intermediate which may be demethylated to provide an inhibitor of catechol-O-methyltransferase useful in the treatment of Parkinson's disease. Also disclosed are methods of making and using said intermediate.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3869`	—
`U-3869`	—

Patent Metadata

Patent number: US9630955
Jurisdiction: US
Classification: Method of Use
Expires: 2032-12-12
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Bial Portela and Cia SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.